FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

412519000: Terazosin hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2693243019 Terazosin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3047090017 Terazosin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2467971015 Terazocin hydrochloride (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2474092010 Terazocin hydrochloride en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2693243019 Terazosin hydrochloride en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2693243019 Terazosin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3047090017 Terazosin hydrochloride (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3047090017 Terazosin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
20241000188110 térazosine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
844331000172116 chlorhydrate de térazosine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
20241000188110 térazosine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
844331000172116 chlorhydrate de térazosine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terazosin hydrochloride (substance) Is a Terazosin false Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance) Has disposition Alpha-1 adrenergic receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance) Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance) Is modification of (attribute) Terazosin true Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance) Is a Substance with alpha-1 adrenergic receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance) Is a Alpha adrenergic receptor antagonist false Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance) Is a Vasodilator (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance) Is a Autonomic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Terazosin hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride 10mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride 5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride 2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin (as terazosin hydrochloride) 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin (as terazosin hydrochloride) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin (as terazosin hydrochloride) 5 mg oral tablet Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin (as terazosin hydrochloride) 10 mg oral tablet Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin (as terazosin hydrochloride) 2 mg oral tablet Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely terazosin (as terazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin (as terazosin hydrochloride) 1 mg oral capsule Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin (as terazosin hydrochloride) 5 mg oral capsule Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely terazosin (as terazosin hydrochloride) 10 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Terazosin hydrochloride dihydrate Is modification of (attribute) True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Terazosin hydrochloride anhydrous (substance) Is modification of (attribute) True Terazosin hydrochloride (substance) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start